J Clin Aesthet Dermatol
Obesity is linked to a laundry list of additional health problems, and those problems become costly for Virginia's $25 billion a year Medicaid program
Curious to hear you #CPG #TheBetterPeer #CPGConsulting #WhatIsChanging #FoodAndBeverage #ConsumerGoods #Innovation #BrandStrategy #GLP1 Richard LimRichard Lim is an Influencer Retail Economist | Shaping the Retail Debate Through Proprietary Research & Insight | CEO & Founder, Retail Economics 38,169 followers GLP-1 weight loss drugs have shifted from a fringe health topic to a boardroom conversation, and the pace at which they are moving into the mainstream is making food and hospitality executives sit up
These medicines may help patients who: Have obesity or overweight with complications Have type 2 diabetes Struggle with insulin resistance Have PCOS Have fatty liver disease Are unable to lose weight despite lifestyle efforts Not every patient requires medication
U-100 syringes convert 1 mL into 100 units
"Allowing compounding, while not the same as drug approval, is nonetheless a nod to regulatory recognition." This time, the FDA's advisors voted 7-5 in favor of putting MOTS-C on the compounding list